FIELD: medicine.
SUBSTANCE: what is described is a method for prediction of pollen bronchial asthma by an immunogenetic study with examining venous blood by polymerase chain reaction (PCR) for DRB1 and DQB1 loci genes of the HLA system, and if observing HLA-DRB1*01 and/or DQB1*05 specificities, a high risk of developing pollen bronchial asthma in the patients with seasonal allergic rhinitis is predicted; if observing HLA-DQB1*06 specificity, resistance to developing pollen bronchial asthma in the patients with seasonal allergic rhinitis is predicted.
EFFECT: higher prediction accuracy in developing pollen bronchial asthma.
1 tbl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING DEVELOPMENT OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2433408C1 |
| METHOD OF PREDICTING POLLINOSIS DEVELOPMENT | 2010 |
|
RU2430360C1 |
| METHOD FOR RISK PREDICTION OF BRONCHIAL ASTHMA | 2012 |
|
RU2510508C1 |
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| ULTRASONIC ENDONASAL DIAGNOSTIC TEST FOR RESPIRATORY ALLERGOSES | 2000 |
|
RU2193863C2 |
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
| METHOD FOR DIAGNOSIS OF ALLERGIC SEVERE BRONCHIAL ASTHMA | 2022 |
|
RU2786010C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF DIABETES MELLITUS TYPE 1 IN BASHKORTOSTAN PEOPLE POPULATIONS | 2005 |
|
RU2285921C1 |
| METHOD OF DETECTING PREDISPOSITION AND RESISTANCE TO DEVELOPMENT OF CYST ECHINOCOCCOSIS IN CHILDREN | 2008 |
|
RU2387383C1 |
| METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
